Skip to main navigation

Back to SpringWorksTx.com
Investors & Media
Contact Us
Linkedin
Twitter

Overview
News & Events
- Press Releases
- Events & Presentations
Corporate Governance
Financial Information
- SEC Filings
- Annual Reports
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Investor Resources
Investors + Media
Medical Professionals
Contact Us
Linkedin
Twitter

Press Releases

Items Per Page

Year

12 Nov 2024

SpringWorks Therapeutics to Participate in the Jefferies London Healthcare Conference

PDF Version

12 Nov 2024

SpringWorks Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

PDF Version

11 Nov 2024

SpringWorks Therapeutics Announces Mirdametinib Data to be Presented at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting

PDF Version

11 Nov 2024

SpringWorks Therapeutics Announces Publication of the Pivotal Phase 2b ReNeu Trial Evaluating Mirdametinib in Adults and Children with NF1-PN in the Journal of Clinical Oncology

PDF Version

07 Nov 2024

SpringWorks Therapeutics Announces Long-Term Efficacy and Safety Data from Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors to be Presented at the Connective Tissue Oncology Society (CTOS) 2024 Annual Meeting

PDF Version

05 Nov 2024

SpringWorks Therapeutics to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference

PDF Version

22 Oct 2024

SpringWorks Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

PDF Version

28 Aug 2024

FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug Application for Mirdametinib for the Treatment of Adults and Children with NF1-PN

PDF Version

07 Aug 2024

SpringWorks Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

PDF Version

29 Jul 2024

SpringWorks Therapeutics Appoints Dr. Martin Mackay to its Board of Directors

PDF Version

Pagination

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Displaying 1 - 10 of 156

Springworks - Toolkits

Print Page
Email Alerts
RSS Feeds
Investor Contacts

Request E-mail Alerts

Social Links

Footer 1

Who We Are
Focus Areas

Footer 2

Pipeline
Careers
- View Opportunities

Footer 3

Patients
Contact

Footer 4

Investors & Media

© 2024 SpringWorks Therapeutics. All rights reserved.

Copyright Links

Privacy Policy
Terms of Use
Cookie Policy